This has led to an increase in pre-competitive and other forms of collaboration to access external innovation and tackle the bottlenecks in drug discovery and development. But pharmaceutical companies continue to hold assumptions about the boundaries of pre-competitive collaboration that need to be challenged.
这样就出现越来越多的竞争前信息共享和其它的一些合作形式，不仅可以获得外界的创新科技，而且可以消除药品开发过程中的瓶颈。但医药公司仍然对竞争前合作形式的界限存有疑问。